Cargando…
In vitro tools for orally inhaled drug products—state of the art for their application in pharmaceutical research and industry and regulatory challenges
The drug development process is a lengthy and expensive challenge for all involved players. Experience with the COVID-19 pandemic underlines the need for a rapid and effective approval for treatment options. As essential prerequisites for successful drug approval, a combination of high-quality studi...
Autores principales: | Metz, Julia Katharina, Hittinger, Marius, Lehr, Claus-Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688684/ http://dx.doi.org/10.1007/s44164-021-00003-8 |
Ejemplares similares
-
Combining MucilAir™ and Vitrocell(®) Powder Chamber for the In Vitro Evaluation of Nasal Ointments in the Context of Aerosolized Pollen
por: Metz, Julia, et al.
Publicado: (2018) -
Inflammatory bowel disease addressed by Caco-2 and monocyte-derived macrophages: an opportunity for an in vitro drug screening assay
por: Schnur, Sabrina, et al.
Publicado: (2022) -
Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications
por: Murteira, Susana, et al.
Publicado: (2014) -
HPLC in the pharmaceutical industry /
Publicado: (1991) -
Immunotoxicology in the pharmaceutical industry.
por: Norbury, K C
Publicado: (1982)